Literature DB >> 16769855

Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy.

Magdalena G Krzystolik1, Theodoros Filippopoulos, Joseph F Ducharme, John I Loewenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769855     DOI: 10.1001/archopht.124.6.920

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

Review 1.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

2.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

Review 3.  New Therapeutic Approaches in Diabetic Retinopathy.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Nidhi Relhan; Krishna S Kishor; Harry W Flynn
Journal:  Rev Diabet Stud       Date:  2015-08-10

4.  Ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis.

Authors:  Yufei Tu; Catherine Fay; Suqin Guo; Marco A Zarbin; Edward Marcus; Neelakshi Bhagat
Journal:  Oman J Ophthalmol       Date:  2012-09

Review 5.  Use of Anti-VEGF Agents in Glaucoma Surgery.

Authors:  Mark Slabaugh; Sarwat Salim
Journal:  J Ophthalmol       Date:  2017-06-27       Impact factor: 1.909

Review 6.  The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.

Authors:  Gemma Tremolada; Claudia Del Turco; Rosangela Lattanzio; Silvia Maestroni; Anna Maestroni; Francesco Bandello; Gianpaolo Zerbini
Journal:  Exp Diabetes Res       Date:  2012-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.